Bernard M van den Berg1, Gangqi Wang1, Margien G S Boels1, M Cristina Avramut2, Erik Jansen3, Wendy M P J Sol1, Franck Lebrin1, Anton Jan van Zonneveld1, Eelco J P de Koning1,3, Hans Vink4, Hermann-Josef Gröne5, Peter Carmeliet6,7, Johan van der Vlag8, Ton J Rabelink9. 1. The Einthoven Laboratory for Vascular and Regenerative Medicine, Division of Nephrology, Department of Internal Medicine, and. 2. Section Electron Microscopy, Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands. 3. Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, University Medical Center Utrecht, Utrecht, The Netherlands. 4. Department of Physiology, Maastricht University Medical Center, Maastricht, The Netherlands. 5. Department of Cellular and Molecular Pathology, The German Cancer Research Center, Heidelberg, Germany. 6. Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, Katholieke Universiteit Leuven, Vesalius Research Center, Vascular Institute Belgium, Leuven, Belgium. 7. Laboratory of Angiogenesis and Vascular Metabolism, Vesalius Research Center, Vascular Institute Belgium, Leuven, Belgium; and. 8. Department of Nephrology, Nijmegen Centre for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands. 9. The Einthoven Laboratory for Vascular and Regenerative Medicine, Division of Nephrology, Department of Internal Medicine, and a.j.rabelink@lumc.nl.
Abstract
BACKGROUND: A glycocalyx envelope consisting of proteoglycans and adhering proteins covers endothelial cells, both the luminal and abluminal surface. We previously demonstrated that short-term loss of integrity of the luminal glycocalyx layer resulted in perturbed glomerular filtration barrier function. METHODS: To explore the role of the glycocalyx layer of the endothelial extracellular matrix in renal function, we generated mice with an endothelium-specific and inducible deletion of hyaluronan synthase 2 (Has2), the enzyme that produces hyaluronan, the main structural component of the endothelial glycocalyx layer. We also investigated the presence of endothelial hyaluronan in human kidney tissue from patients with varying degrees of diabetic nephropathy. RESULTS: Endothelial deletion of Has2 in adult mice led to substantial loss of the glycocalyx structure, and analysis of their kidneys and kidney function showed vascular destabilization, characterized by mesangiolysis, capillary ballooning, and albuminuria. This process develops over time into glomerular capillary rarefaction and glomerulosclerosis, recapitulating the phenotype of progressive human diabetic nephropathy. Using a hyaluronan-specific probe, we found loss of glomerular endothelial hyaluronan in association with lesion formation in tissue from patients with diabetic nephropathy. We also demonstrated that loss of hyaluronan, which harbors a specific binding site for angiopoietin and a key regulator of endothelial quiescence and maintenance of EC barrier function results in disturbed angiopoietin 1 Tie2. CONCLUSIONS: Endothelial loss of hyaluronan results in disturbed glomerular endothelial stabilization. Glomerular endothelial hyaluronan is a previously unrecognized key component of the extracelluar matrix that is required for glomerular structure and function and lost in diabetic nephropathy.
BACKGROUND: A glycocalyx envelope consisting of proteoglycans and adhering proteins covers endothelial cells, both the luminal and abluminal surface. We previously demonstrated that short-term loss of integrity of the luminal glycocalyx layer resulted in perturbed glomerular filtration barrier function. METHODS: To explore the role of the glycocalyx layer of the endothelial extracellular matrix in renal function, we generated mice with an endothelium-specific and inducible deletion of hyaluronan synthase 2 (Has2), the enzyme that produces hyaluronan, the main structural component of the endothelial glycocalyx layer. We also investigated the presence of endothelial hyaluronan in human kidney tissue from patients with varying degrees of diabetic nephropathy. RESULTS: Endothelial deletion of Has2 in adult mice led to substantial loss of the glycocalyx structure, and analysis of their kidneys and kidney function showed vascular destabilization, characterized by mesangiolysis, capillary ballooning, and albuminuria. This process develops over time into glomerular capillary rarefaction and glomerulosclerosis, recapitulating the phenotype of progressive humandiabetic nephropathy. Using a hyaluronan-specific probe, we found loss of glomerular endothelial hyaluronan in association with lesion formation in tissue from patients with diabetic nephropathy. We also demonstrated that loss of hyaluronan, which harbors a specific binding site for angiopoietin and a key regulator of endothelial quiescence and maintenance of EC barrier function results in disturbed angiopoietin 1Tie2. CONCLUSIONS: Endothelial loss of hyaluronan results in disturbed glomerular endothelial stabilization. Glomerular endothelial hyaluronan is a previously unrecognized key component of the extracelluar matrix that is required for glomerular structure and function and lost in diabetic nephropathy.
Authors: G Thurston; J S Rudge; E Ioffe; H Zhou; L Ross; S D Croll; N Glazer; J Holash; D M McDonald; G D Yancopoulos Journal: Nat Med Date: 2000-04 Impact factor: 53.440
Authors: Linda Madisen; Theresa A Zwingman; Susan M Sunkin; Seung Wook Oh; Hatim A Zariwala; Hong Gu; Lydia L Ng; Richard D Palmiter; Michael J Hawrylycz; Allan R Jones; Ed S Lein; Hongkui Zeng Journal: Nat Neurosci Date: 2009-12-20 Impact factor: 24.884
Authors: Davide Vigetti; Sara Deleonibus; Paola Moretto; Eugenia Karousou; Manuela Viola; Barbara Bartolini; Vincent C Hascall; Markku Tammi; Giancarlo De Luca; Alberto Passi Journal: J Biol Chem Date: 2012-08-10 Impact factor: 5.157
Authors: Gaganpreet Kaur; Yuefan Song; Ke Xia; Kevin McCarthy; Fuming Zhang; Robert J Linhardt; Norman R Harris Journal: Glycobiology Date: 2022-07-13 Impact factor: 5.954
Authors: Gesa L Tiemeier; Gangqi Wang; Sébastien J Dumas; Wendy M P J Sol; M Cristina Avramut; Tobias Karakach; Valeria V Orlova; Cathelijne W van den Berg; Christine L Mummery; Peter Carmeliet; Bernard M van den Berg; Ton J Rabelink Journal: Stem Cell Reports Date: 2019-10-31 Impact factor: 7.765
Authors: Gangqi Wang; Margreet R de Vries; Wendy M P J Sol; Annemarie M van Oeveren-Rietdijk; Hetty C de Boer; Anton Jan van Zonneveld; Paul H A Quax; Ton J Rabelink; Bernard M van den Berg Journal: Cells Date: 2020-03-29 Impact factor: 6.600